Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mother Sparsh sees up to 40% growth as baby-care boom defies consumer slowdown
Mother Sparsh anticipates a robust 30-40% revenue surge this year, defying broader consumption slowdowns. Indian parents are prioritizing their babies' health and well-being, investing in premium, 'no nasties' products. Leveraging ITC's extensive distribution, the brand aims to expand its reach beyond online channels into smaller cities, tapping into a growing demand for trusted, scientifically-backed baby care solutions.
Why Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades
Dr. Lal PathLabs founder Arvind Lal on why Indians are dying of heart attacks in their 40s, why health insurance won't cover the tests that could prevent it, and what five basic blood tests every Indian should get by 25.
JM Fin on insurance: Retail health to drive growth; Star Health top pick
The brokerage said that it prefers Star Health in the space as it has recommended a 'Buy' rating on the stock for a target price of ₹650.
Cipla appoints health chief Shivam Puri to lead One India business
Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take effect from July 1. Puri currently heads Cipla Health, a role he has held since 2019. His extensive experience in consumer goods and healthcare will now steer Cipla's domestic operations.
ICICI Lombard: AI Integration Lifts Growth Outlook — Buy, Sell or Hold? Read Motilal Oswal's Analysis
Leadership in motor insurance, accelerating momentum in retail health, expanding distribution capabilities, growing AI integration and a strong balance sheet remains ICICI Lombard's key growth drivers.
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
Retail health premium growth rises to 31% YoY in April 2026, anchoring non-life insurance sector: Kotak Institutional Securities
Indian non-life insurance saw robust growth in April 2026. Retail health premiums surged 31 percent year-on-year. Motor insurance also performed well. Private players and standalone health insurers are gaining market share from public sector companies. Commercial lines faced challenges, though marine and engineering segments showed resilience. This indicates a dynamic shift in the insurance landscape.
Apollo Hospitals FY26 profit jumps 34% to Rs 1,942 crore on growth across core businesses
Apollo Hospitals announced robust financial results for the fourth quarter and the full fiscal year 2026. Consolidated revenue and net profit saw significant year-on-year increases. Growth was fueled by its healthcare services, diagnostics, and retail health segments. The company is expanding its bed capacity and focusing on underserved markets.
Stock market today: From Swiggy, IRFC to RVNL— More than 700 stocks hit 52-week lows on BSE amid stock market crash
As many as 719 stocks, including Swiggy, SBI Cards and Payment Services, IRFC, RVNL, REC, Concor, DLF, Naukri, Page Industries, Procter & Gamble Hygiene and Health Care, and Shree Cement, hit their 52-week lows in intraday trade on the BSE.
ACC clears Dr Rajeev Singh Raghuvanshi’s reappointment as Drugs Controller (India)
Dr Rajeev Singh Raghuvanshi will continue as Drugs Controller (India) at CDSCO. His reappointment is on a contract basis for one year starting March 1, 2026. This decision follows a proposal from the Department of Health and Family Welfare. Dr Raghuvanshi heads the CDSCO, responsible for drug quality and new drug approvals.
Gaudium IVF shares list at 5% premium over issue price
The IPO of Gaudium IVF and Women Health was subscribed 7.27 times at close, driven by sustained demand from retail and non-institutional investors.
Gaudium IVF IPO: Issue subscribed 0.90 times on Day 1; retail portion fully booked, GMP signals healthy debut
Gaudium IVF and Women Health's IPO opened on February 20, attracting significant investor interest with 0.87 times subscription. The company aims to raise ₹165 crore for expansion and operational needs. The listing is planned for February 27, 2026, with shares priced between ₹75-79.